3-Methylsalicylic acid

3-Methylsalicylic acid (CAS No.: 83-40-9) is a salicylic acid derivative widely utilized in biomedical research as a small-molecule modulator of fibrinolytic processes and as a synthetic intermediate in medicinal chemistry. Functionally, it has been shown to enhance fibrinolytic activity in human plasma by promoting activation of the fibrinolytic system, facilitating the conversion of plasminogen to plasmin through modulation of associated signaling pathways, thereby supporting its use in studies of thrombotic disease mechanisms and hemostatic balance. Although precise molecular targets remain incompletely defined, its activity is associated with regulation of proteolytic cascades involved in clot degradation. In vitro investigations indicate measurable bioactivity within low micromolar to higher concentration ranges depending on assay conditions, consistent with other small-molecule modulators of fibrinolysis. Beyond its biological effects, 3-methylsalicylic acid serves as a versatile intermediate for the synthesis of bioactive derivatives, including salicylamides with reported anticancer activity and salt forms of therapeutic agents, supporting its relevance in drug discovery and lead optimization workflows. It has also been explored in niche biological contexts such as insect feeding inhibition, reflecting broader bioactivity. In experimental settings, concentrations or doses are typically selected based on specific model systems, including plasma-based assays, cell culture studies, and preclinical models aimed at evaluating fibrinolytic modulation and therapeutic potential.